Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compensatory Cognitive Training For Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04040998
Recruitment Status : Completed
First Posted : August 1, 2019
Last Update Posted : August 1, 2019
Sponsor:
Information provided by (Responsible Party):
YU SHIUAN LIAW, Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

Brief Summary:
This study aimed to investigate the effects of compensatory cognitive training plus treatment as usual (CCT+TAU) versus treatment as usual (TAU) on on self-esteem, self-efficacy, quality of life, and self-stigma for schizophrenia.

Condition or disease Intervention/treatment Phase
Schizophrenia Behavioral: Compensatory Cognitive Training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 46 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Compensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia
Actual Study Start Date : January 5, 2018
Actual Primary Completion Date : May 31, 2018
Actual Study Completion Date : May 31, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Arm Intervention/treatment
Experimental: CCT+TAU group
The participants in CCT+TAU group received compensatory cognitive training plus treatment as usual. The CCT intervention consisted of two 50-minute sessions each week for 10 weeks
Behavioral: Compensatory Cognitive Training
Teach the participants compensatory cognitive skills and strategies

No Intervention: TAU group
The participants in TAU group received usual treatment at the same time as CCT+TAU group.



Primary Outcome Measures :
  1. Change scores of Rosenberg Self-Esteem Scale (RSES) [ Time Frame: 3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention ]
    The Chinese version of Rosenberg Self-Esteem Scale (RSES) was implemented as self-esteem measures. The total score ranged from 10 to 40, with higher scores reflecting higher levels of self-esteem.

  2. Change scores of General Self-Efficacy Scale (GSES) [ Time Frame: 3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention ]
    The Chinese version of General Self-Efficacy Scale (GSES) consisted of 10 items, assessing optimistic self-beliefs to cope with a variety of difficult demands in life. The total score ranged from 10 to 40, with higher scores indicating more self-efficacy.

  3. Change scores of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) [ Time Frame: 3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention ]
    The Chinese version of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) was administered to measure subjective quality of life. The total scores ranged from 33-165, with higher scores indicating comparatively lower quality of life.

  4. Change scores of Internalized Stigma of Mental Illness (ISMIS) [ Time Frame: 3 times: 1 to 2 weeks before intervention, 1 day after intervention and at 1 month after intervention ]
    The Chinese version of Internalized Stigma of Mental Illness (ISMIS) consists of 29 items incorporated in five domains: alienation, stereotype endorsement, discrimination experience, social withdrawal, and stigma resistance. The total scores range from 29-116. The higher scores on the ISMIS indicates more severe internalized stigmatization.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of schizophrenia, based on the ICD-10 diagnostic criteria for research (World Health Organization, 1992)
  • age from 20 to 65
  • attending day care center regularly for at least 3 months
  • taking stable dose of medication for at least 3 months

Exclusion Criteria:

  • comorbid autism spectrum disorder
  • comorbid mental retardation
  • lacking the reading and writing skills

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04040998


Locations
Layout table for location information
Taiwan
Taoyuan Psychiatric Center Ministry of Health and Welfare
Taoyuan, Taiwan, 330
Sponsors and Collaborators
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

Layout table for additonal information
Responsible Party: YU SHIUAN LIAW, Occupational Therapist, Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
ClinicalTrials.gov Identifier: NCT04040998     History of Changes
Other Study ID Numbers: TaoyuanMH
First Posted: August 1, 2019    Key Record Dates
Last Update Posted: August 1, 2019
Last Verified: July 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by YU SHIUAN LIAW, Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan:
schizophrenia
compensatory cognitive training
generalized estimating equation
psychosocial correlates
self-stigma
Additional relevant MeSH terms:
Layout table for MeSH terms
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders